(Q88075857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

[Imaging in smoldering (asymptomatic) multiple myeloma. Past, present and future] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

M Bhutani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

O Landgren

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

1 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

572, 574-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.

20 March 2020

cites work

1 reference

12 December 2020

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

1 reference

12 December 2020

The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi

1 reference

12 December 2020

Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

1 reference

12 December 2020

Lead time gained by diagnostic screening for breast cancer

1 reference

12 December 2020

Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.

1 reference

12 December 2020

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

1 reference

12 December 2020

Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?

1 reference

12 December 2020

Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging

1 reference

12 December 2020

Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)

1 reference

12 December 2020

18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment.

1 reference

12 December 2020

Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

1 reference

12 December 2020

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

1 reference

12 December 2020

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

1 reference

12 December 2020

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

1 reference

12 December 2020

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

1 reference

12 December 2020

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

1 reference

12 December 2020

Whole-body (18)F-FDG PET identifies high-risk myeloma.

1 reference

12 December 2020

Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load

1 reference

12 December 2020

Diagnosis of smoldering multiple myeloma

1 reference

12 December 2020

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

1 reference

12 December 2020

Risk of disease progression in asymptomatic multiple myeloma

1 reference

12 December 2020

Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial

1 reference

12 December 2020

Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy

1 reference

12 December 2020

Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology

1 reference

12 December 2020

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

1 reference

12 December 2020

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

1 reference

12 December 2020

Multiple myeloma precursor disease.

1 reference

12 December 2020

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

1 reference

12 December 2020

Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

1 reference

12 December 2020

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

1 reference

12 December 2020

Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.

1 reference

12 December 2020

18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation

1 reference

12 December 2020

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review

1 reference

12 December 2020

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

1 reference

12 December 2020

The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.

1 reference

12 December 2020

Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey

1 reference

12 December 2020

Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma

1 reference

12 December 2020

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

1 reference

12 December 2020

Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma

1 reference

12 December 2020

Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation

1 reference

12 December 2020

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

1 reference

12 December 2020

Smoldering multiple myeloma requiring treatment: time for a new definition?

1 reference

12 December 2020

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

1 reference

12 December 2020

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).

1 reference

12 December 2020

Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. II

1 reference

12 December 2020

Iterative reconstruction technique for reducing body radiation dose at CT: feasibility study

1 reference

12 December 2020

The radiological demonstration of osseous metastases. Experimental observations

1 reference

12 December 2020

Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.

1 reference

12 December 2020

Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results

1 reference

12 December 2020

Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring

1 reference

12 December 2020

Relationship between bone marrow cellularity and apparent diffusion coefficient

1 reference

12 December 2020

Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications

1 reference

12 December 2020

Some pitfalls in the evaluation of screening programs

1 reference

12 December 2020

10.1007/S00117-014-2694-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927659%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference